Search details
1.
Phenotypic characterisation of SMAD4 variant carriers.
J Med Genet
; 2024 Apr 04.
Article
in English
| MEDLINE | ID: mdl-38575304
2.
Disrupted BMP-9 Signaling Impairs Pulmonary Vascular Integrity in Hepatopulmonary Syndrome.
Am J Respir Crit Care Med
; 2024 Apr 16.
Article
in English
| MEDLINE | ID: mdl-38626313
3.
Large-scale phosphoproteomics reveals activation of the MAPK/GADD45ß/P38 axis and cell cycle inhibition in response to BMP9 and BMP10 stimulation in endothelial cells.
Cell Commun Signal
; 22(1): 158, 2024 03 04.
Article
in English
| MEDLINE | ID: mdl-38439036
4.
BMP9 and BMP10: Two close vascular quiescence partners that stand out.
Dev Dyn
; 251(1): 178-197, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34240497
5.
Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease.
Mem Inst Oswaldo Cruz
; 117: e210395, 2022.
Article
in English
| MEDLINE | ID: mdl-35239842
6.
Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.
Circ Res
; 124(6): 846-855, 2019 03 15.
Article
in English
| MEDLINE | ID: mdl-30636542
7.
Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis.
Hepatology
; 70(4): 1392-1408, 2019 10.
Article
in English
| MEDLINE | ID: mdl-30964206
8.
A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
J Biol Chem
; 293(28): 10963-10974, 2018 07 13.
Article
in English
| MEDLINE | ID: mdl-29789425
9.
BMP9 and BMP10 are necessary for proper closure of the ductus arteriosus.
Proc Natl Acad Sci U S A
; 112(25): E3207-15, 2015 Jun 23.
Article
in English
| MEDLINE | ID: mdl-26056270
10.
Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function.
Hum Mol Genet
; 24(4): 1142-54, 2015 Feb 15.
Article
in English
| MEDLINE | ID: mdl-25312062
11.
Response by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".
Circ Res
; 124(9): e82-e83, 2019 04 26.
Article
in English
| MEDLINE | ID: mdl-31021726
12.
Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation.
Blood
; 122(4): 598-607, 2013 Jul 25.
Article
in English
| MEDLINE | ID: mdl-23741013
13.
BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
Blood
; 119(25): 6162-71, 2012 Jun 21.
Article
in English
| MEDLINE | ID: mdl-22566602
14.
Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances.
J Clin Invest
; 134(4)2024 Feb 15.
Article
in English
| MEDLINE | ID: mdl-38357927
15.
BMP9 is a key player in endothelial identity and its loss is sufficient to induce arteriovenous malformations.
Cardiovasc Res
; 120(7): 782-795, 2024 May 29.
Article
in English
| MEDLINE | ID: mdl-38502919
16.
BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.
Cell Mol Life Sci
; 69(2): 313-24, 2012 Jan.
Article
in English
| MEDLINE | ID: mdl-21710321
17.
Warning regarding hematological toxicity of tamoxifen activated CreERT2 in young Rosa26CreERT2 mice.
Sci Rep
; 13(1): 5976, 2023 04 12.
Article
in English
| MEDLINE | ID: mdl-37045870
18.
TGFß1 inhibits lymphatic endothelial cell differentiation from mouse embryonic stem cells.
J Cell Physiol
; 227(11): 3593-602, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22287283
19.
Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations.
Blood
; 116(9): 1604-12, 2010 Sep 02.
Article
in English
| MEDLINE | ID: mdl-20501893
20.
Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.
JAMA
; 307(9): 948-55, 2012 Mar 07.
Article
in English
| MEDLINE | ID: mdl-22396517